Advertisement

Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      In the rabbit, dietary cholesterol downregulates the hepatic LDL receptor and concomitant treatment with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors partly restores its expression. The aim of this study was to determine whether the LDL receptor activity of circulating mononuclear cells would reflect the changes seen in liver. New Zealand White rabbits were fed for 3 weeks either a normal diet or diets containing 0.25% (w/w) cholesterol, 0.25% cholesterol plus 22 mg/kg per day pravastatin or 0.25% cholesterol plus 6 mg/kg per day simvastatin. Dietary cholesterol increased plasma cholesterol 8.9-fold, liver membrane cholesterol 1.8-fold and bile cholesterol saturation 2.3-fold, and decreased the LDL receptor activities of liver and mononuclear cells by 69% and 58%, respectively. In the cholesterol-fed rabbit, pravastatin decreased plasma cholesterol by 55%, liver membrane cholesterol by 29% and bile cholesterol saturation by 23%, and increased liver and mononuclear cell LDL receptor activities by 120% and 77%, respectively. Similarly, simvastatin decreased plasma cholesterol by 74%, liver membrane cholesterol by 24% and bile cholesterol saturation by 38%, and increased liver and mononuclear cell LDL receptor activities by 80% and 62%, respectively. Liver and mononuclear cell LDL receptor activities were directly correlated (r = 0.73, P < 0.005) and both activities were inversely correlated with plasma cholesterol concentration in a log-linear fashion (r = -0.70, P < 0.005 and r = -0.69, P < 0.01, respectively). The LDL receptor activity of mononuclear cells therefore reflected the hepatic LDL receptor activity in these rabbits.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rudling M.J.
        • Reihnér E.
        • Einarsson K.
        • Ewerth S.
        • Angelin B.
        Low density lipoprotein receptor-binding activity in human tissues: Quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.
        in: Proc. Natl. Acad. Sci. USA. 87. 1990: 3469
        • Pittman R.C.
        • Attie A.D.
        • Carew T.E.
        • Steinberg D.
        Tissue sites of degradation of low density lipoprotein: Application of a method for determining the fate of plasma proteins.
        in: Proc. Natl. Acad. Sci. USA. 76. 1979: 5345
        • Böyum A.
        Isolation of mononuclear cells and granulocytes from human blood.
        Scand. J. Clin. Lab. Invest. 1968; 97: 77
        • Bilheimer D.W.
        • Ho Y.K.
        • Brown M.S.
        • Anderson R.G.W.
        • Goldstein J.L.
        Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.
        J. Clin. Invest. 1978; 61: 678
        • Mistry P.
        • Miller N.E.
        • Laker M.
        • Hazzard W.R.
        • Lewis B.
        Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.
        J. Clin. Invest. 1981; 67: 493
        • Hagemenas F.C.
        • Illingworth D.R.
        Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
        Arteriosclerosis. 1989; 9: 355
        • Kovanen P.T.
        • Brown M.S.
        • Basu S.K.
        • Bilheimer D.W.
        • Goldstein J.L.
        Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits.
        in: Proc. Natl. Acad. Sci. USA. 78. 1981: 1396
        • Chao Y.S.
        • Kroon P.A.
        • Yamin T.T.
        • Thompson G.M.
        • Alberts A.W.
        Regulation of hepatic receptordependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starchcasein diet.
        Biochim. Biophys. Acta. 1983; 754: 134
        • Ma P.T.S.
        • Gil G.
        • Südhof T.C.
        • Bilheimer D.W.
        • Goldstein J.L.
        • Brown M.S.
        Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.
        in: Proc. Natl. Acad. Sci. USA. 83. 1986: 8370
        • Ishida F.
        • Watanabe K.
        • Sato A.
        • Taguchi K.
        • Kakubari K.
        • Kitani K.
        • Kamei T.
        Comparative effects of simvastatin (MK-733) and pravastatin (CS-514) on hypercholesterolemia induced by cholesterol feeding in rabbits.
        Biochim. Biophys. Acta. 1990; 1042: 365
        • Ludders J.W.
        • Thomas C.B.
        • Sharp P.
        • Sedgwick C.J.
        An anesthetic technique for repeated collection of blood from New Zealand White rabbits.
        Lab. Anim. Sci. 1987; 37: 803
        • Roach P.D.
        • Noël S.P.
        Solubilization of the 17α-ethinyl estradiol-stimulated low density lipoprotein receptor of male rat liver.
        J. Lipid Res. 1985; 26: 713
        • Whiting M.J.
        • Watts J.M.
        Role of cholic acid in the dietary induction of cholesterol gallbladder stones in mice.
        J. Gastroenterol. Hepatol. 1987; 2: 547
        • Roach P.D.
        • Zollinger M.
        • Noël S.P.
        Detection of the low density lipoprotein (LDL) receptor on nitrocellulose paper with colloidal gold-LDL conjugates.
        J. Lipid Res. 1987; 28: 1515
        • Stone B.G.
        • Evans C.D.
        • Prigge W.F.
        • Duane W.C.
        • Gebhard R.L.
        Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mono nuclear leukocytes of normal subjects.
        J. Lipid Res. 1989; 30: 1943
        • Traber M.G.
        • Kayden H.
        Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages.
        Arterosclerosis. 1984; 52: 1
        • Roach P.D.
        • Kambouris A.M.
        • Trimble R.P.
        • Topping D.L.
        • Nestel P.J.
        The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat.
        FEBS Lett. 1987; 222: 159
        • Topping D.L.
        • Illman R.J.
        • Roach P.D.
        • Trimble R.P.
        • Kambouris A.
        • Nestel P.J.
        Modulation of the hypolipidemic effect of fish oils by dietary fiber in rats: studies with rice and wheat bran.
        J. Nutr. 1990; 120: 325
        • Goldstein J.L.
        • Brown M.S.
        The low-density lipoprotein pathway and its relation to atherosclerosis.
        Annu. Rev. Biochem. 1977; 46: 897
        • Meddings J.B.
        • Dietschy J.M.
        Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low density lipoprotein turnover in man.
        Circulation. 1986; 74: 805
        • Khosla P.
        • Samman S.
        • Carroll K.K.
        Decreased receptor-mediated LDL catabolism in casein-fed rabbits precedes the increase in plasma cholesterol levels.
        J. Nutri. Biochem. 1991; 2: 203
        • Reihnér E.
        • Rudling M.
        • Ståhlberg D.
        • Berglund L.
        • Ewerth S.
        • Björkhem L.
        • Einarsson K.
        • Angelin B.
        Influence of pravastatin, a specific inhibitor of HMG CoA reductase, on hepatic metabolism of cholesterol.
        N. Engl. J. Med. 1990; 323: 224